文献速递肾癌与肾肿瘤

美国肾癌微创手术的趋势与费用:一项基于人群的研究

Trends and Costs of Minimally Invasive Surgery for Kidney Cancer in the US: A Population-based Study.
PubMed 文献 · Urology · 2024-04-24

该回顾性观察性队列分析利用美国全国保险账单数据库,纳入80821例肾癌微创手术,分析过去十年微创手术趋势与费用,并评估健康社会决定因素对围手术期结局的影响。微创部分肾切除术占比显著上升(回归斜率=0.026,P<.001),微创根治性肾切除术费用最高(26.9千美元±40.9千美元),肾消融费用最低(18.9千美元±31.6千美元)。

要点

  • 微创部分肾切除术占全部微创手术的比例显著上升(回归斜率=0.026,P<.001)。
  • 微创根治性肾切除术费用最高(26.9千美元±40.9千美元),肾消融费用最低(18.9千美元±31.6千美元)。
  • 各治疗组间并发症数量(P=.06)和健康社会决定因素存在情况(P=.07)无统计学显著差异。

核心结论

  • 本研究描述了美国肾癌的当前管理方式,并从社会经济角度阐述了该疾病在日常临床实践中的影响。

研究设计与样本

  • 回顾性观察性队列分析,使用美国全国保险账单记录数据库PearlDiver Mariner。
  • 共纳入80821例肾癌微创手术。
  • 采用国际疾病分类和当前操作术语代码识别微创手术人群并按治疗方式分层。
  • 使用国际疾病分类代码评估健康社会决定因素。
  • 采用负二项回归评估肾微创手术总体数量,Cochran-Armitage检验比较研究期间不同治疗方式的使用情况。

主要发现

  • 微创部分肾切除术占全部微创手术的比例显著上升(回归斜率=0.026,P<.001)。
  • 微创根治性肾切除术费用为26.9千美元±40.9千美元,肾消融费用为18.9千美元±31.6千美元,分别为最贵和最便宜的手术。
  • 各治疗组间并发症数量(P=.06)和健康社会决定因素存在情况(P=.07)无统计学显著差异。
  • 多变量分析中,存在健康社会决定因素的患者接受微创根治性肾切除术后围手术期并发症的比值比更高,而肾消融的围手术期并发症概率显著更低。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyze temporal trends and costs associated with the use of minimally invasive surgery (MIS) for kidney cancer in the US over the past decade. To examine the impact of social determinants of health (SDOH) on perioperative outcomes. METHODS: The PearlDiver Mariner, a national database of insurance billing records, was queried for this retrospective observational cohort analysis. The MIS population was identified and stratified according to treatment modality, using International Classification of Diseases and current procedural terminology codes. SDOH were assessed using International Classification of Diseases codes. Negative binomial regression was used to evaluate the overall number of renal MIS and Cochran-Armitage tests to compare the utilization of different treatment modalities, over the study period. Multivariable logistic regression analysis identified predictors of perioperative complications. RESULTS: A total of 80,821 MIS for kidney cancer were included. Minimally invasive partial nephrectomy adoption as a fraction of total MIS increased significantly (slope of regression line, reg. = 0.026, P <.001). Minimally invasive radical nephrectomy ($26.9k ± 40.9k) and renal ablation ($18.9k ± 31.6k) were the most expensive and cheapest procedures, respectively. No statistically significant difference was observed in terms of number of complications (P = .06) and presence of SDOH (P = .07) among the treatment groups. At multivariable analysis, patients with SDOH undergoing minimally invasive radical nephrectomy had higher odds of perioperative complications, while renal ablation had a significantly lower probability of perioperative complications. CONCLUSION: This study describes the current management of kidney cancer in the US, offering a socioeconomic perspective on the impact of this disease in everyday clinical practice.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Ditonno F, Franco A, Manfredi C, et al. Trends and Costs of Minimally Invasive Surgery for Kidney Cancer in the US: A Population-based Study. Urology. 2024. PMID: 38670274. doi:10.1016/j.urology.2024.03.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。